Contract Research Organization (CRO) Market Size Worth USD 155 Billion by 2030 at 11.7% CAGR - Report by Market Research Future (MRFR)

Contract Research Organization (CRO) Market Trends and Insights By Segment (Drug Discovery, Clinical Development), By Clinical Trial Phase (Preclinical Trials, Phase I, Phase II, Phase III), By End Users (Pharmaceutical Companies), Competitive Market Growth, Size, Share and Forecast to 2030

New York, USA, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Contract Research Organization Market Overview:

According to a Comprehensive Research Report by Market Research Future (MRFR), “Contract Research Organization Market Information By Segment, By Clinical Trial Phase, By End Users - Forecast till 2030, the market size is predicted to reach USD 155 Billion at 11.7% CAGR in the forecast period (2022-2030).

CRO Market Scope:

Contract research organizations (CROs) provide a variety of useful services to industries including healthcare, biotechnology, government, pharma, and more that rely heavily on research. Data management, clinical operations, regulatory, quality assurance, and submission services are all in high demand in these sectors.

Get Free Sample PDF Brochure @

Report Scope:

Report AttributeDetails
Market Size in 2030USD 155 Billion
Base Year2021
Forecast Period2022-2030
Historical Data2020
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredBy Clinical Trial Phase, Segment and End User
Geographies CoveredNorth America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market DriversAvailability of funds and government support for research & development
Rising healthcare expenditures and increasing patient population across the world

CRO Market Competitive Dynamics:  

Competition amongst players is fierce in the current market. There has never been a greater urgency to deliver quality service. The most effective tactics for succeeding in the market today are expansion, mergers, and partnerships. In the future, more growth is predicted. 

The key players of the contract research organization (CRO) market are 

  • ICON 
  • Laboratory Corporation of America holdings 
  • PRA health science 
  • Pharmaceutical product development 
  • INC research 
  • IQVIA 
  • Med pace 
  • KCR 
  • Paracel international company 

Contract Research Organization Market Dynamics:

Market Drivers

Several key factors, including the availability of research funds, government support for R&D, a growing well-developed healthcare sector and rising healthcare expenditures, and a growing patient population across the world, are fueling explosive growth in the global Contract Research Organization (CRO) market over the forecast period.

Increasing amounts of money are being set aside for research and development in the pharmaceutical and biotech sectors. Pharmaceutical and commercial market advancements are the results of study in these sectors. The considerable spending on research will provide for lucrative rewards for these sectors. The pharmaceutical industry's investment in the contract research organization sector is crucial.

Agreements and contracts will rise as a result of the introduction of new products. Accordingly, these sectors depend critically on competent contract services. Multiple economies and markets are expanding in terms of both production and size. As output rises, so does the profitability of all markets. Contract research services are especially important at the moment. Global market tendencies shift as a result of massive shifts in manufacturing. During these market manipulations, the demand for research contracts tends to increase.

As a result of these elements, demand for contract research organization (cro) services and applications will rise. More people are learning about the benefits of contract research services. These contract services offer significant benefits. It can keep businesses safe from a variety of threats. Contracts ensured everyone's protection. In addition, both the contractor and the client stand to gain from these services. All these factors are what will propel the contract research organization industry to new heights of growth.

Market Restraints

Contract market services are very costly. The high cost of labor in the market is an issue that could slow growth within the predicted time frame. The process of establishing patents and commercial contracts is complex. Since this is the case, the market's labor cost is quite high. Since the price is prohibitive, interest is waning in several markets. Contract services must be reasonably priced across most sectors.

The industry as a whole has to spend more money on operations because of this high price. Other market challenges come from the ever-shifting nature of industries. Constant revisions to contracts are inevitable. These shifts in the industry have an impact on how the market functions. The demand and supply pattern in the contract research organization (CRO) industry may be thrown off by several market limitations. It also stunts development of the market for CROs, which conducts research for companies.

Browse In-depth Market Research Report (90 Pages) on Contract Research Organization (CRO):

COVID-19 Analysis:

Several major pharmaceutical and biopharmaceutical companies have increased their research and development and production efforts to develop and market SARS-CoV-2 viral diagnostic kits, vaccines, and treatments during the COVID-19 epidemic and pandemic. Long-term agreements, partnerships, and collaborations between pharmaceutical and biotechnology companies and CROs have been established all over the world in an effort to hasten the R&D process. Contract research groups are also interested in the COVID-19 project (CROs).

Several additional services have been introduced, and several agreements, partnerships, and collaborations have been formed with various pharmaceutical companies and academic institutions to advance the study and development of COVID-19 vaccines, treatments, and diagnostics. The funding also includes the construction of new factories. Therefore, the entire pharmaceutical contract research business has benefited from the COVID-19 pandemic as it has served as an impetus for outsourcing drug development procedures.

Buy Now:

CRO Market Segmentation:

The contract research organization market has been segmented into clinical trial phase, end-users and segments.

By Segment

Over the estimated time frame of the study, the drug discovery industry is anticipated to be the market's primary driver.

By Clinical Trial Phase

There will be significant growth in the preclinical trials industry during the assessment period.

By End-User

Over the forecasted time frame, the pharmaceutical industry is anticipated to be the market's primary driver.

Share your Queries @

Contract Research Organization Market Regional Analysis:

For contract research organizations, the future in North America looks bright. The region's significant concentration of pharmaceutical and biotechnology firms is largely responsible for the market's rapid expansion. Additionally, the pharmaceutical and biotechnology companies' growing interest in contracting out clinical trials for the purpose of treating a wide range of disorders is projected to fuel growth in this region's industry. The region's supremacy can be attributed to a number of factors, including the presence of numerous major pharmaceutical companies, a robust drug research industry, and a well-developed healthcare system. The pharmaceutical industry has recently begun to outsource more clinical studies in an effort to cure a wider variety of diseases. As a corollary, these businesses are spending more money on research and development.

The CRO services market in Europe was the second largest in the world, and it is expected to maintain this position throughout the projection period. The increased prevalence of diseases is to blame. Also, pharmaceutical firms increasingly rely on contract research groups for increased efficiency and productivity in light of rising healthcare costs.

Discover more research reports on Healthcare Industry, by Market Research Future:

Drug Discovery Services Market Research Report: By Drug Type (Small Molecule Drug, Biologics), by Type (DMPK, Pharmaceutical Services, Others), by Therapeutic Area (Oncology, Others), by Process, by Technology, and by End-User – Global Forecast Till 2030

Clinical Trials Market Research Report: by Phase (Phase I, Phase II, Phase III) by Study Design (Interventional, Observational and Expanded Access), Indication (Autoimmune/Inflammation) by End User (Medical Institutes, Hospitals)-Forecast Till 2030

Preclinical CRO Market: Information By Service (Toxicology Testing, Bioanalysis and Drug Metabolism and Pharmacokinetics (DMPK) Studies), Application (Oncology, Central Nervous System (CNS) Disorders, Cardiovascular Diseases, Immunological Disorders, Respiratory Diseases, Infectious Diseases, Diabetes), End User (Pharmaceutical and Biopharmaceutical Industries, Medical Device Companies and Academic Institutes) - Forecast till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter


Contact Data